Last updated: Mar 27, 2024
- Brand NameMolbio
- HeadquarterGoa
- No. of Employees450
- Industry
Healthcare
- Founded Year 2010
- Company StatusActive
- Highlights
- Total Funding₹970.19 Cr
- Funding Rounds3
- Number of Acquisition1
- FY 2021-22 Revenue₹781.57 Cr
- FY 2021-22 Profit₹215.15 Cr
About Molbio
Molbio Diagnostics, brings to the healthcare professionals worldwide the "TruelabTM Real Time quantitative micro PCR system", that makes Real Time PCR testing simple and possible in all laboratories, in the field and in near-patient settings. The smart design of the hardware and the room temperature stable reagent microchip make the assay robust and aff.....
Business Model of Molbio
Healthcare diagnostic firm Molbio Diagnostics’ flagship product Truenat provides real-time IoT-enabled testing kits for over 40 diseases in addition to TB, including COVID-19, hepatitis, HIV, HPV, and vector-borne diseases like dengue, chikungunya, and malaria.
Key People/Management
Show allSN
Sriram NatarajanDirector
CB
Chandrasekhar Bhaskaran NairDirector
SS
Sangeetha SriramDirector
MK
Mulangi Krishnaswamy AshokkumarDirector
RB
Rohit Brijmohan MantriNominee Director
SN
Sriram NatarajanFounder & CEO
Top Competitors
PR
PractoU72900KA2008PTC046374
3H
3hcareU85200DL2021PTC379169
PC
Pristyn CareU85300HR2018PTC075460
QU
Qure.aiU74999MH2016PTC283891
Latest News
- PE-backed Molbio’s Natarajan on revenue growth and why it isnt chasing M and AsMay 29, 2023
- Motilal Oswal PE-backed Molbio Diagnostics acquires Prognosys MedicalFeb 20, 2023
- Molbio becomes second unicorn in Sep with $1.5 Bn valuationSep 29, 2022
- Temasek invests USD 85 mn in Molbio DiagnosticsSep 27, 2022
- From Rs 51 Cr in FY20 to Rs 1,272 Cr revenue in FY21: The story of Molbio DiagnosticsJul 25, 2022
- Molbio Diagnostics gets DCGI nod for Nipah virus testingSep 9, 2021
- Temasek in talks to buy into Covid test kit-maker MolbioJul 12, 2021
- Company Watch: Motilal Oswal PE backed Molbio to break even in FY21, grow revenues 30XMar 10, 2021
- Motilal Oswal PE bets on Molbio Diagnostics in new healthcare betMar 5, 2020